Efficacy, patterns of relapse and safety of adjuvant treatment with intraperitoneal (i.p.) yttrium-90-labeled HMFG1 monoclonal antibody (R1549) in epithelial ovarian cancer (EOC)

LFAG Massuger; A. Lopes; AA Epenetos; M.V. Seiden; BB Benigno; JT Soper; J. Markowska; R Vyzula; RHM Verheijen; T Jobling

Efficacy, patterns of relapse and safety of adjuvant treatment with intraperitoneal (i.p.) yttrium-90-labeled HMFG1 monoclonal antibody (R1549) in epithelial ovarian cancer (EOC)

LFAG Massuger
, A. Lopes
, AA Epenetos
, M.V. Seiden
, BB Benigno
, JT Soper
, J. Markowska
, R Vyzula
, RHM Verheijen
, T Jobling

Research output: Contribution to conference › Abstract › Other research output

Original language	English
Publication status	Published - 2004
Event	IGCS - Edinburgh, Ireland Duration: 3 Oct 2004 → 8 Oct 2016

Conference

Conference	IGCS
Country/Territory	Ireland
City	Edinburgh
Period	3/10/04 → 8/10/16

Cite this

@conference{0aac52c48baf4a789c9649b850cddba2,

title = "Efficacy, patterns of relapse and safety of adjuvant treatment with intraperitoneal (i.p.) yttrium-90-labeled HMFG1 monoclonal antibody (R1549) in epithelial ovarian cancer (EOC)",

author = "LFAG Massuger and A. Lopes and AA Epenetos and M.V. Seiden and BB Benigno and JT Soper and J. Markowska and R Vyzula and RHM Verheijen and T Jobling",

year = "2004",

language = "English",

note = "IGCS ; Conference date: 03-10-2004 Through 08-10-2016",

}

TY - CONF

T1 - Efficacy, patterns of relapse and safety of adjuvant treatment with intraperitoneal (i.p.) yttrium-90-labeled HMFG1 monoclonal antibody (R1549) in epithelial ovarian cancer (EOC)

AU - Massuger, LFAG

AU - Lopes, A.

AU - Epenetos, AA

AU - Seiden, M.V.

AU - Benigno, BB

AU - Soper, JT

AU - Markowska, J.

AU - Vyzula, R

AU - Verheijen, RHM

AU - Jobling, T

PY - 2004

Y1 - 2004

M3 - Abstract

T2 - IGCS

Y2 - 3 October 2004 through 8 October 2016

ER -